Hanmi Pharm. Co., Ltd. (KRX:128940)

Hanmi Pharm. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,036,911	3,556,800	4,473,421	3,711,167	3,373,870	4,397,245
Market Cap Growth	-20.49%	-20.49%	20.54%	10.00%	-23.27%	25.97%
Enterprise Value	3,496,262	4,027,046	4,935,354	4,226,778	4,030,879	5,216,052
Last Close Price	239500.00	280500.00	350901.20	290409.65	263266.61	342142.63
PE Ratio	25.03	29.32	30.59	44.83	50.34	367.69
Forward PE	20.89	19.54	30.57	38.01	44.63	95.75
PS Ratio	2.03	2.38	3.00	2.79	2.80	4.09
PB Ratio	2.45	2.87	4.07	3.68	3.64	5.29
P/TBV Ratio	2.92	3.42	4.92	4.51	4.47	6.44
P/FCF Ratio	19.69	23.06	23.65	28.14	18.54	40.08
P/OCF Ratio	15.70	18.38	20.66	22.87	16.71	29.02
PEG Ratio	6.33	-	-	-	-	-
EV/Sales Ratio	2.34	2.69	3.31	3.17	3.35	4.85
EV/EBITDA Ratio	11.28	13.00	15.26	16.86	18.79	47.28
EV/EBIT Ratio	16.45	18.95	21.95	27.47	32.14	106.50
EV/FCF Ratio	22.67	26.11	26.09	32.05	22.15	47.54
Debt / Equity Ratio	0.40	0.40	0.52	0.67	0.82	0.96
Debt / EBITDA Ratio	1.60	1.60	1.77	2.71	3.53	7.27
Debt / FCF Ratio	3.22	3.22	3.03	5.14	4.16	7.31
Asset Turnover	0.76	0.76	0.78	0.69	0.63	0.57
Inventory Turnover	2.30	2.30	2.38	2.37	2.04	1.56
Quick Ratio	0.63	0.63	0.61	0.62	0.67	0.56
Current Ratio	1.09	1.09	1.04	1.03	1.08	1.15
Return on Equity (ROE)	12.00%	12.00%	15.68%	10.48%	9.26%	2.09%
Return on Assets (ROA)	6.78%	6.78%	7.35%	4.98%	4.11%	1.61%
Return on Capital (ROIC)	7.79%	7.79%	8.37%	5.71%	4.72%	1.85%
Return on Capital Employed (ROCE)	15.90%	15.90%	18.80%	12.30%	9.70%	3.60%
Earnings Yield	399.47%	3.41%	3.27%	2.23%	1.99%	0.27%
FCF Yield	507.84%	4.34%	4.23%	3.55%	5.39%	2.50%
Payout Ratio	1034.94%	10.35%	12.31%	7.24%	8.77%	68.07%
Buyback Yield / Dilution	8.30%	0.08%	0.09%	0.12%	0.11%	0.09%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.